We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.15B
AUM Growth
+$171M
Cap. Flow
-$50.7M
Cap. Flow %
-1.61%
Top 10 Hldgs %
39.38%
Holding
234
New
3
Increased
16
Reduced
102
Closed
4

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$69.5M
2
APO icon
Apollo Global Management
APO
+$21.5M
3
BB icon
BlackBerry
BB
+$7.83M
4
LUMN icon
Lumen
LUMN
+$5.06M
5
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
+$1.86M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$20.2M
2
JEF icon
Jefferies Financial Group
JEF
+$15.3M
3
BAX icon
Baxter International
BAX
+$13.3M
4
LBTYA icon
Liberty Global Class A
LBTYA
+$12.6M
5
ABT icon
Abbott
ABT
+$6.71M

Sector Composition

Rank Sector Weight
1 Financials 29.01%
2 Healthcare 16.47%
3 Technology 12.09%
4 Communication Services 10.94%
5 Energy 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
L icon
201
Loews
L
$24.5B
$211K 0.01%
4,200
– –
QQQ icon
202
Invesco QQQ Trust
QQQ
$436B
$209K 0.01%
+1,126
New +$204K
GAM
203
General American Investors Company
GAM
$1.54B
$200K 0.01%
+5,416
New +$195K
KEY icon
204
KeyCorp
KEY
$23.8B
$199K 0.01%
10,000
– –
HPE icon
205
Hewlett Packard
HPE
$58.8B
$196K 0.01%
12,000
– –
AGFSW
206
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$178K 0.01%
887,983
-7,700
-0.9% -$1.95K
GCVRZ
207
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$174K 0.01%
329,129
-100
-0% -$54
PBT
208
Permian Basin Royalty Trust
PBT
$1.36B
$103K ﹤0.01%
12,900
– –
ESTRW
209
DELISTED
Estre Ambiental, Inc
ESTRW
$92K ﹤0.01%
264,148
– –
KHC icon
210
Kraft Heinz
KHC
$32.8B
– –
-3,314
Closed -$208K
META icon
211
Meta Platforms (Facebook)
META
$1.49T
– –
-1,061
Closed -$206K
VCMP
212
DELISTED
VCAMPUS CORP
VCMP
$0 ﹤0.01%
59,956
– –
JPM.PRG
213
DELISTED
JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non
JPM.PRG
– –
-8,000
Closed -$211K
5 6 7 8
9

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q3 2018 Portfolio in Review

As of Q3 2018, Beck Mack & Oliver held 234 positions worth $3.15B, up 5.7% from $2.98B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3%. Beck Mack & Oliver opened 3 new positions and exited 4, leaving the 234-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q3 2018 buy was Teva Pharmaceuticals: 2,993,705 shares worth $64.5M.
  • Beck Mack & Oliver added most to Apollo Global Management in Q3 2018, an estimated $21.5M increase.
  • Beck Mack & Oliver's biggest Q3 2018 reduction was Merck, cutting an estimated $20.2M.
  • Beck Mack & Oliver fully exited JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non in Q3 2018, selling an estimated $211K.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $3.15B portfolio in Q3 2018.
  • Beck Mack & Oliver opened 3 new positions and closed 4 in Q3 2018.
  • Beck Mack & Oliver's portfolio value rose 5.7% quarter-over-quarter to $3.15B.

Based on Beck Mack & Oliver's 13F filing for Q3 2018, filed 29 Oct 2018.